Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
3 astronauts settle into their new life in orbit | On the International Space Station this week Dec. 1-5, 2025 - 2Novo Nordisk gears up for December Ozempic launch in India, sources say
- 3Cygnus XL brings cargo to the ISS for 1st time | Space photo of the day for Dec. 1, 2025
- 4Telescope in Chile captures stunning new picture of a cosmic butterfly
- 5Practice environmental safety in Style: Divulging Famous Electric Vehicle Brands
- Nestlé recalls infant formula in 49 countries. See list.
- Manual for Tracking down the Immaculate Magnificence of Focal Asia
- The many ways that baking is winter therapy. With a delicious ending
- Promising Speculation Bearings for Portfolio Development in 2024
- What Yogurt Types Do You Know
- Pfizer says patient dies after receiving hemophilia drug in trial
- UN chief warns he could refer Israel to ICJ over laws targetting UNRWA
- Most loved Amusement Park Firecrackers Show: Which One Lights Up Your Evening?
- Hamas propaganda expert explains Israel's internal conflicts influenced Hamas's Oct. 7 assault
